» Articles » PMID: 23240614

The Multi-faceted Role of Allergen Exposure to the Local Airway Mucosa

Overview
Journal Allergy
Date 2012 Dec 18
PMID 23240614
Citations 16
Authors
Affiliations
Soon will be listed here.
Abstract

Airway epithelial cells are the first to encounter aeroallergens and therefore have recently become an interesting target of many studies investigating their involvement in the modulation of allergic inflammatory responses. Disruption of a passive structural barrier composed of epithelial cells by intrinsic proteolytic activity of allergens may facilitate allergen penetration into local tissues and additionally affect chronic and ongoing inflammatory processes in respiratory tissues. Furthermore, the ability of rhinoviruses to disrupt and interfere with epithelial tight junctions may alter the barrier integrity and enable a passive passage of inhaled allergens through the airway epithelium. On the other hand, epithelial cells are no longer considered to act only as a physical barrier toward inhaled allergens, but also to actively contribute to airway inflammation by detecting and responding to environmental factors. Epithelial cells can produce mediators, which may affect the recruitment and activation of more specialized immune cells to the local tissue and also create a microenvironment in which these activated immune cells may function and propagate the inflammatory processes. This review presents the dual role of epithelium acting as a passive and active barrier when encountering an inhaled allergen and how this double role contributes to the start of local immune responses.

Citing Articles

Neuropeptide S and its receptor aggravated asthma via TFEB dependent autophagy in bronchial epithelial cells.

Wang Z, Zhao P, Yan G, Sun A, Xu L, Li J Respir Res. 2025; 26(1):50.

PMID: 39930427 PMC: 11812264. DOI: 10.1186/s12931-025-03125-9.


The extracellular serine protease from elicits a type 2-biased immune response in atopic dermatitis patients.

Abdurrahman G, Pospich R, Steil L, Salazar M, Izquierdo Gonzalez J, Normann N Front Immunol. 2024; 15:1352704.

PMID: 38895118 PMC: 11183529. DOI: 10.3389/fimmu.2024.1352704.


Developments in the Management of Severe Asthma in Children and Adolescents: Focus on Dupilumab and Tezepelumab.

van Dijk Y, Rutjes N, Golebski K, Sahin H, Hashimoto S, der Zee A Paediatr Drugs. 2023; 25(6):677-693.

PMID: 37658954 PMC: 10600295. DOI: 10.1007/s40272-023-00589-4.


New insights into the pathophysiology and therapeutic targets of asthma and comorbid chronic rhinosinusitis with or without nasal polyposis.

Striz I, Golebski K, Strizova Z, Loukides S, Bakakos P, Hanania N Clin Sci (Lond). 2023; 137(9):727-753.

PMID: 37199256 PMC: 10195992. DOI: 10.1042/CS20190281.


Oral Mucosa as a Potential Site for Diagnosis and Treatment of Allergic and Autoimmune Diseases.

Gomez-Casado C, Sanchez-Solares J, Izquierdo E, Diaz-Perales A, Barber D, Escribese M Foods. 2021; 10(5).

PMID: 33925074 PMC: 8146604. DOI: 10.3390/foods10050970.